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A new service delivery system for the treatment of opioid dependence, called motivational stepped 
care, matches the intensity of counseling services to each patient’s clinical progress. Adherence to a
counseling schedule is reinforced through the linking of counseling attendance with the patient’s
methadone dispensing schedule and, ultimately, his or her ability to continue receiving treatment 
services. The article describes the scientific evidence supporting the major elements of the model, the
model in action, and evaluations that have been conducted to date.
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T
he effectiveness of methadone treatment in reducing use of heroin and other opi-
oids has been confirmed in studies spanning more than three decades but has declined
in recent years. One factor in this development is greater scope and severity of problems
among current patients than among their counterparts in the mid-1960s. The changing
clinical profile includes high rates of use of cocaine and other drugs (e.g., Brooner et al.,
1997), high rates of psychiatric and other life-threatening health problems (e.g., Brooner
et al., 1997), high rates of unemployment (Platt, 1995), and an expanding drug culture
that isolates patients from drug-free social supports (e.g., Latkin et al., 1995). While there
has always been a subgroup of opioid-dependent patients who use other drugs and have
other serious health and social problems, the growing number of such patients has pro-
duced an acute need for more comprehensive and intensive services.
Several general strategies have been tried to improve the functioning of drug-depend-
ent patients. Simply intensifying routine drug abuse counseling improves outcomes for
patients receiving methadone, and even better response can be achieved with more spe-
cialized interventions (e.g., Woody et al., 1995). This work has led to a critical principle
in the treatment of drug abuse: Providing appropriate intensities of proven psychological
interventions enhances patients’ response to medications. Yet many programs deliver only
limited counseling. Inadequate funding, large caseloads, and overextended counseling staff
partially account for this problem. However, even when sufficient counseling is avail-
able, even in well-designed and adequately funded treatment studies, patients often attend
fewer than half of their scheduled sessions (Kidorf et al., 1999). The consequences are less
effective therapy and reduced staff morale.SCIENCE AND PRACTICE IN ACTION—BEHAVIORAL REINFORCEMENT • 39
This article presents a therapeutic approach that
integrates the use of methadone with routine and spe-
cialized counseling. The approach, called motivational
stepped care (MSC), is designed to motivate patients
to attend counseling sessions, even when scheduled
frequently, and to help them achieve at least brief peri-
ods of abstinence through a clear and predictable set
of behavioral contingencies. It is based on the stepped-
care approach that has been used with patients who
have alcohol or other psychiatric problems (e.g.,
Davison, 2000) and uses a simple matching principle
in which people who respond poorly to treatment are
moved to greater intensities of care, while those who
respond well receive less intensive services. As shown
in Figure 1, new patients begin treatment at Step 1
and move to greater intensities of care according to
their rates of counseling attendance and drug-posi-
tive urine specimens.
SCIENTIFIC BASIS FOR MSC
Three main principles underlie the MSC model. All
have been repeatedly validated by empirical research.
Psychosocial Interventions Are Effective
The importance of individual and group counseling
for drug-dependent patients was recognized by the
founders of methadone treatment, and counseling has
always been a standard part of medication therapy.
Empirically validated counseling interventions can
help patients identify problem areas, establish rational
targets for step-by-step improvement, adhere to
program guidelines and procedures, recognize progress
in treatment, and cope with occasional relapses.
Counselors also use sessions to provide and facilitate
referrals related to needs that cannot be met within
the program, for example, medical and psychiatric
care, housing, and legal help. Studies have shown that
individual and group counseling, case management
services, and professional psychotherapy improve
methadone treatment by reducing drug use, increas-
ing employment, and fostering other changes impor-
tant to recovery.
A study by McLellan and colleagues (1993) illus-
trates both that counseling services are, in general,
important to treatment outcome and that more coun-
seling often produces better results. Methadone patients
who were randomly assigned to receive standard coun-
seling plus additional psychiatric and medical services
achieved more consecutive weeks of opioid- and cocaine-
negative urine samples than did patients who received
only standard counseling or no counseling. In con-
trast, patients assigned to receive no counseling did
so poorly that standard counseling was added to the
treatment for many, who then improved rapidly,
significantly reducing both cocaine and heroin use
within 1 month.
Stepped Care Is Effective and Cost-Sensitive
The amount of counseling necessary to maximize ther-
apeutic response varies from patient to patient and
program to program. Indeed, the amount needed to
initiate or sustain good response by a single patient
may vary at different stages of therapy, especially dur-
ing long-term treatment. 
Stepped-care treatment models have been shown
to provide a rational and flexible system for deter-
mining what quantity of services an individual patient
needs at any point during treatment for alcohol abuse
and other psychiatric problems. These models are also
gaining acceptance among drug abuse clinicians and
researchers. Stepped care initiates treatment services
at a “least restrictive” level and moves the patient to
more intensive and invasive schedules only if the
response is poor. Each patient is thus matched to
the least intensive, least costly intervention necessary
to achieve his or her best clinical response. 
The stepped-care service delivery approach has
considerable relevance to the treatment of opioid
dependence. Some patients respond well to minimal
counseling, while others respond poorly, with high
rates of missed sessions and continuing drug use.
Maintaining good responders at the minimal levels
while assigning poor responders to more intensive
counseling schedules—at least for brief periods—is a
cost-sensitive approach well suited to the need of  pro-
grams using methadone to make the best possible use
of their limited resources for providing services.
A feature of stepped care is that patients who are
among the least likely to attend minimal counseling
sessions are assigned even more sessions. To overcome
this apparent paradox, programs must include inter-
ventions to motivate attendance, particularly at more
intense levels of service.
Contingency Management Incentives Can
Reinforce Counseling Attendance
Contingency management promotes greater treat-
ment participation by linking it to services patients
People who
respond poorly
to treatment
are moved to
greater intensi-
ties of care,
while those
who respond
well receive 
less intensive 
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value. Programs that use methadone offer many serv-
ices that can be used as contingencies to promote coun-
seling attendance and other important behavior changes,
such as reducing drug use and getting a job (see review
by Kidorf and Stitzer, 1999) (Table 1). Such inter-
ventions are most effective when they are adminis-
tered consistently and applied proximately to target 
behaviors.
Behavioral contingencies have been implemented
in many treatment programs with varying degrees
of success. Contingent take-home doses of medica-
tion have been associated with only modest reduc-
tions in drug use (Kidorf and Stitzer, 1996); better
results have been seen when take-home doses are used
to improve counseling attendance (Kidorf et al., 1994;
Methadone Taper and Discharge
• 30 -day taper to zero dose
• reversible if patient attends all 
scheduled counseling for 1 
week
• discharged patients guaranteed
readmission within 24 hours
Step 3 (4 to 8 weeks)
• one to two individual counseling 
sessions/week
• eight group counseling sessions/ 
week (includes significant-other 
group)
• weekly urine testing
• methadone dose adjustment as 
needed
Step 2 (2 to 4 weeks)
• one individual counseling session/ 
week
• three to four group counseling 
sessions/week
• weekly urine testing
• methadone dose adjustment as 
needed
Step 1 (variable duration)
• one counseling session/week
• individual counseling
• weekly urine testing
• methadone dose adjustment as
needed
Patient Admitted and Stabilized
(4 weeks) 
• induction to initial methadone 
maintenance dose
• weekly urine testing 
Methadone Medical Maintenance
(variable duration)
• one to two counseling sessions/
month
• individual counseling
• two urine tests/month
• methadone dose adjustment as 
needed
FIGURE 1. Motivational Stepped Care Approach*
applies to all patients
responds well
responds poorly
* Programs can tailor counseling content and movement across steps to fit their resources and patient 
populations
Iguchi et al., 1988). However, some unstable patients
may sell or misuse the take-home medication.
Another widely used approach involves increas-
ing the medication dose to reward counseling atten-
dance or drug abstinence, and applying dose reduc-
tions for missed counseling sessions or continued drug
use (Stitzer et al., 1986). This approach is a workable
but more short-term intervention because dose increases
may be limited by a ceiling effect, and dose reductions
can worsen response and lead to discharge.
A more recent approach to contingency man-
agement involves issuing vouchers for goods and serv-
ices to reward reductions in drug use. While the voucher
system has produced good results (Silverman et al.,
1996), most community programs cannot purchaseSCIENCE AND PRACTICE IN ACTION—BEHAVIORAL REINFORCEMENT • 41
items to use as rewards for abstinence or counseling
attendance.
One of the more effective behavioral reinforce-
ment strategies in drug abuse treatment, and among
the easiest to adopt in community settings, is con-
tingent access to ongoing treatment services. This
approach often involves telling patients they will be
discharged from the program if they continue using
drugs. While it works for some patients, special meas-
ures are needed to prevent unintended high rates of
discharge (Zanis and Woody, 1998). 
Sustaining behavioral changes motivated by con-
tingency management interventions can also be prob-
lematic, especially among drug abusers mired in social
networks that reinforce continued drug use (Hawkins
and Fraser, 1987; Latkin et al., 1995). Azrin devel-
oped a community reinforcement intervention that
utilizes the support of spouses and significant others
to improve medication adherence, provide social and
other reinforcement contingent on abstinence, and
help patients become involved in social activities (e.g.,
Azrin et al., 1994). While this intervention has been
used mainly with patients suffering from alcohol prob-
lems, it can be used with opioid abusers who have
drug-free family members or friends.
THE MSC MODEL
The MSC service delivery approach was implemented
in 1992 by the Addiction Treatment Services pro-
gram at Johns Hopkins Bayview Medical Center.
At that time, we were seeing increasing cocaine and
heroin use by patients, 12-month retention rates were
dropping, and most patients were failing to attend
the modestly increased counseling services offered to
them.
Patients avoiding counseling sessions is a prob-
lem shared by nearly all drug abuse programs. Given
the effectiveness of counseling, it is intuitively clear
that missed counseling sessions must have an impact
on outcomes (see “Missed Counseling Sessions = Less
Therapeutic Effectiveness,” page 43). The MSC sys-
tem was designed to increase the intensity of services
available to poor responders and to motivate them to
attend counseling by linking the continuation of serv-
ices to their attendance and to documented absti-
nence of modest duration (2 to 4 weeks) (Brooner et
al., 1996; Kidorf et al., 1999).  
MSC employs three aspects of standard opioid
agonist treatment as incentives:  
• Daily medication dosing time. Early medication
dosing times are offered only to patients who reg-
ularly attend scheduled counseling sessions. The
more sessions a patient misses, the later his or her
clinic dosing is scheduled.
• The amount of required weekly counseling.Patients
who regularly attend scheduled counseling sessions
and produce drug-negative urine specimens are
offered the option of fewer counseling sessions.
Patients who persistently miss counseling sessions
and/or continue to use drugs are assigned to inten-
sified counseling schedules. The desire to avoid this
contingency motivates some patients to adhere to
their current counseling schedules and/or achieve
brief periods of abstinence. For those who do not
improve, the increased frequency of counseling as
well as greater expertise of counselors (most coun-
seling in the intensified schedules is group-based
and delivered by senior staff members) enhances
the potential benefit of the intervention.
• Continued availability of treatment. Patients who
have been moved along to the most intense level of
counseling and continue to miss counseling ses-
sions are tapered off their opioid agonist medica-
tion and discharged from the program. 
Two elements of the MSC model require further expla-
nation to allay potential concerns. First, the linkage
of counseling intensity to therapeutic goals utilizes
the behavioral principle of an avoidance schedule, in
which some patients reduce drug use and attend rou-
tine counseling to avoid more intensive weekly coun-
seling at higher steps. Some treatment experts have
expressed concern that the MSC model relies partly
upon the patient’s desire to minimize exposure to
counseling to motivate clinical progress. They argue
that if counseling services are of high quality, patients
will naturally seek them out, rather than avoid them.
We believe that patients who make clinical progress
because of a desire to avoid more intensive interven-
tions have made a rational choice. People with other
medical problems are often encouraged by health pro-
fessionals to change specific behaviors to avoid more
intensive and invasive interventions, and such patients
are commended when they succeed.
Some observers have interpreted the MSC model’s
ultimate contingency, the 30-day medication taper,42 • SCIENCE & PRACTICE PERSPECTIVES—JULY 2002 
All patients
receive educa-
tion about 
the structured
steps of care.
attendance at all scheduled counseling sessions. All
changes in counseling intensities are based upon meas-
urable factors, namely, rates of drug-positive urine
specimens and counseling attendance, which are mon-
itored weekly by the clinical staff. All patients receive
education about the structured steps of care at admis-
sion and throughout their therapy to ensure that they
understand the treatment plan and the consequences
of missing counseling sessions and uninterrupted use
of drugs.
One important feature of an MSC approach is
the ability of each program to establish its own cri-
teria for changing counseling intensities. This encour-
ages programs to select thresholds that are well suited
to the special characteristics of the populations they
serve.  
Patients newly admitted to our MSC program
begin treatment in Step 1 (standard care) after a 4-
week stabilization period, and they are scheduled to
attend one 30-minute individual counseling session
per week. We generally resist the temptation to start
treatment at more intense steps for patients with par-
ticularly severe drug use disorder or other psychiatric
problems. We have observed that some of the more
severely affected patients respond well to Step 1, so
greater intensities of care would be cost-ineffective as
well as unnecessarily disruptive to them. Starting patients
at more intense levels of care might also increase resist-
ance to the intervention and produce high rates of fail-
ure and discharge. Delaying the use of more intensive
services until a patient provides evidence of poor response
can improve the acceptability of the intervention. This
approach is also consistent with the way medication is
used in many programs. For example, new patients are
often started on relatively low doses of methadone 
(30 mg to 40 mg daily) and advanced to higher doses
only as needed to manage continuing opioid with-
drawal symptoms or drug craving.
Patients in Step 1 who achieve and sustain good
clinical response—for example, documented absti-
nence and attending all sessions—for several months
are shifted to a case management status —methadone
medical maintenance—that gradually reduces pro-
gram reporting to once every 14 to 30 days, for an
individual counseling session and renewal of medica-
tion supply. This intensity of care constitutes the least
intensive service available in the program. Step 1
patients who produce drug-positive urine specimens
as punishment for the poorly responding patient, but
this is not its intent. Rather, this intervention was
adopted to utilize the principle of behavioral rein-
forcement, linking a highly valued outcome—the
ongoing availability of opioid agonist medication—
to therapeutic objectives. In effect, the MSC approach
uses methadone to eliminate opioid withdrawal, sup-
press drug craving, and reinforce greater participation
in the treatment plan.
Patients retain considerable control over the
process and can reverse tapers simply by adhering to
the treatment plan for 1 week. Most importantly,
patients who choose to leave the program rather than
attend counseling sessions in Step 3—the most inten-
sive step of the program—are told they can return to
the program as soon as 1 day later if they simply agree
to attend all scheduled counseling sessions. Guaranteed
readmission remains in place for 30 days, and patients
return to the Step 3 schedule.
In summary, the MSC therapeutic model fully
integrates the three major elements of a comprehen-
sive system of care: access to a wide range of medica-
tions and doses, access to a wide range of counseling
interventions and intensities, and use of behavioral
reinforcement to motivate counseling attendance. The
model’s overall goal is to retain patients in treatment
and provide each one with the psychosocial interven-
tions most likely to improve his or her outcomes. Its
structural and dynamic aspects are consistent with
stepped-care models described by others (e.g., Davison,
2000), in which treatment intensity is increased
only for those who demonstrate a need for additional 
service.
MSC produces a treatment plan with predictable
responses to the changing decisions and problems that
patients express and therefore maximizes the goal of
individualized care. It is also cost-effective, by direct-
ing more intensive and specialized services only to
those doing poorly. The escalating intensities of weekly
counseling also impose an extra measure of structure
on the daily lives of drug-using patients who remain
disorganized and unproductive.
MSC IN ACTION
The MSC delivery system provides three distinct inten-
sities of weekly counseling, clear guidelines for move-
ment between the steps, and a process that ultimately
links the continuation of the treatment episode withSCIENCE AND PRACTICE IN ACTION—BEHAVIORAL REINFORCEMENT • 43
and/or miss counseling sessions in any 2 consecutive
weeks after the 4-week stabilization period are moved
along to Step 2.
Step 2 patients are scheduled to receive one indi-
vidual counseling session and three to four group ses-
sions per week for 2 to 4 weeks. The manual-guided
counseling groups teach skills including relapse con-
trol, job training, stress management, abstinence role
recovery, coping with urges to use drugs and other
problems, and time management. Senior clinical per-
sonnel deliver most group counseling services, which
increases cost-effectiveness and avoids overburdening
the primary counseling staff, many of whom man-
age caseloads of 40 or more patients. Counselor and
patient together decide on group assignments, which
are based on the patient’s needs and work schedule;
services are provided between 7 a.m. and 8 p.m. on
weekdays. Step 2 patients who attend all their sched-
uled sessions and provide drug-negative urine samples
for 2 consecutive weeks return to Step 1 for ongoing
care. Step 2 patients who continue to miss counseling
sessions and/or use drugs are reassigned to Step 3.
The counseling schedule in Step 3 consists of one
to two individual sessions and eight group sessions per
week. One of the required groups for Step 3 patients
is a manual-guided significant-other intervention that
is based on the community reinforcement literature
(Hunt and Azrin, 1973). This intervention requires
patients to enlist the help of drug-free family or friends
to attend group counseling and help them develop or
expand drug-free social supports. Patients who attend
all counseling sessions and remain drug-free for 4 con-
secutive weeks are returned to Step 1, although the
significant-other group meeting remains in place for
a few weeks to ensure a successful transition to less
intensive service. Patients in Step 3 who continue to
miss counseling sessions and use drugs are discharged
after completing a 30-day medication taper.   
Patients discharged from the program have pro-
vided considerable evidence of their unwillingness to
follow the clearly articulated plan of care. Although it
is tempting to keep such patients in the program any-
way, doing so can dilute the effectiveness of treatment
by allowing them to persistently avoid the services
most likely to improve their functioning. Patients who
choose a 30-day medication taper in preparation for
discharge are reminded daily that attending scheduled
counseling sessions for 1 week will stop the taper. Many
patients begin attending sessions during this period.
Those who complete the 30-day medication taper are
Missed Counseling Sessions = Less Therapeutic Effectiveness
H
igh rates of missed counseling sessions appear to be a pervasive and long-standing problem in programs offering
methadone and other agonist medications. Nyswander and colleagues (1958) commented more than four decades
ago on the small percentage of drug abusers who participated in available counseling. The high rates of missed counseling
visits relative to missed medication visits in programs using opioid agonist medications reflects the view that counseling is
supplementary and subordinate to the medication (Kidorf et al., 1994). This bias can be observed in programs that dis-
charge patients who miss several consecutive days of medication, yet take no action when patients miss numerous coun-
seling sessions. Such policies can have the unintended effect of communicating to the staff and patients the view that med-
ication is the primary  treatment, the intervention most likely to produce the largest and most sustained changes in
behavior. So it is not particularly surprising when programs describe patients who regularly appear for medication but van-
ish before counseling can be delivered.
Many clinical trials that have evaluated the efficacy of psychosocial services have either failed to report rates of coun-
seling attendance or documented only modest rates (Kidorf et al., 1999). Given the overall effectiveness of counseling,
these studies may have produced even more impressive outcomes if more of the scheduled service were actually delivered
to patients. Proper evaluation of the potential impact of counseling on the extent of rehabilitation is difficult when the inter-
vention is delivered at low doses, intermittently, and unpredictably. While considerable attention is directed toward efforts
to match patients to specific types of verbal or behavioral therapies, the more central problem is how to motivate patients
to regularly attend even routine counseling sessions. The MSC therapeutic approach is designed to address this core prob-
lem that, if unresolved, will continue to limit the effectiveness of most counseling interventions.44 • SCIENCE & PRACTICE PERSPECTIVES—JULY 2002 
discharged “against medical advice” and are guaran-
teed readmission as soon as 1 day later.
In the MSC model, discharge is a reversible inter-
vention designed to motivate adherence to the treat-
ment plan. The rapid-readmission intervention also
encourages patients to return to the same program the
next time they seek care. Patients with chronic drug
use disorder often have histories of multiple episodes
of care delivered by different programs. Increasing the
likelihood of a patient’s return to the same program
is advantageous because experience gained in the
preceding episode of care can inform the new treat-
ment plan.
EVALUATION OF THE MSC APPROACH
Several preliminary reports have been published using
data from a randomized, controlled study evaluating
the effectiveness of MSC for patients receiving methadone.
These reports found that counseling attendance was
significantly higher with MSC than with standard care
(about 80 percent vs. 30 percent) and that rates of
heroin use were lower (Bigelow et al., 1998; Brooner
et al., 1996; Carter et al., 2000). Retention of patients
was good and comparable across MSC and standard
care—about 90 percent. The final report of this study
is completed and is being
submitted for publica-
tion; results for the entire
sample of participants
are comparable to those
reported here.
Another study was
conducted in our pro-
gram to evaluate the
impact of attention-
deficit/hyperactivity dis-
order (ADHD) on the
treatment response of
drug abusers (King et al.,
1999). That study is pre-
sented here because the
MSC approach was used
to treat all of the patients,
and outcomes were eval-
uated over a longer period
(12 months) than stud-
ies specifically designed
to assess the MSC model.
New patients were clas-
sified as having or not having ADHD, and all were
treated with the MSC approach. In both groups, more
than 75 percent were retained in treatment for the
entire year, and more than 60 percent of all urine spec-
imens were negative for heroin, cocaine, sedatives, and
alcohol.
Recently, serendipity provided a unique oppor-
tunity to compare our patients’ outcomes to those of
patients in Baltimore’s eight other publicly funded
programs that use methadone. The City of Baltimore
mandated that all publicly funded drug abuse treat-
ment programs track retention rates at 1, 6, and 
12 months; collect urine specimens at least twice
monthly; and test the specimens in the same certified
laboratory. The MSC approach produced the lowest
rate of opioid-positive and cocaine-positive urine spec-
imens, with 6- and 12-month retention rates similar
to or better than the comparison programs (Baltimore
City Health Department, unpublished data).
The available evidence from these evaluations
indicates that the MSC approach can be used effec-
tively with opioid abusers to motivate counseling atten-
dance and reduce drug use, without producing high
rates of discharge from treatment. Still, even though
our program is community-based, it remains unclear
TABLE 1. Effectiveness of Clinic-Based, Behavior-Contingent Incentives
All studies documented improvements in the targeted behaviors except Magura et al. (1988) (no effect) and
Iguchi et al. (1988) (negative effect). Treatment outcome for each study was determined by rates of counsel-
ing attendance, urinalysis results, job acquisition, and/or involvement of significant others.
Clinic-based incentive          Target behavior                       Study
Contingent take-home    Increased drug-free                Milby et al. (1978); Magura et al. (1988);
medication     urine specimens                    Stitzer et al. (1992); Kidorf and Stitzer (1996)
Improved counseling              Stitzer et al. (1977); Iguchi et al. (1996)
attendance
Decreased self-reported          Iguchi et al. (1988)
drug use
Contingent methadone  Increased drug-free                  Glosser (1983); Stitzer et al. (1986);
dose alterations  urine specimens Higgins et al. (1986); Iguchi et al. (1988)
Involvement of significant      Kidorf et al. (1997)
other
Job acquisition                         Kidorf et al. (1998)
Contingent treatment  Increased drug-free                  McCarthy and Borders (1985); Dolan et al.(1985);
availability  urine specimens Kidorf and Stitzer (1993); Kidorf et al. (1999)
Improved counseling                Kidorf et al. (1999)
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whether MSC will work as well in other programs.  A
large-scale, randomized replication in community clin-
ics outside the control of our clinical research team
will show whether this new approach to working with
opioid-dependent patients is a “hothouse” model (one
that requires unique attention for success) or a hardier
approach that adapts successfully to most programs. 
MSC OUTSTANDING ISSUES 
Essential Elements
Most programs offering methadone or other agonist
medications already have the elements necessary to
implement an MSC approach, with the possible excep-
tion of high-intensity counseling services. Programs
with a limited counseling staff may be able to obtain
good patient outcomes with MSC using schedules that
require considerably less counseling input than we cur-
rently use. The primary concern in setting counseling
schedules is that patients clearly recognize that each
forward step is distinctly more intense and each back-
ward step distinctly less intense.  We originally required
only 6 hours of counseling per week in Step 3 and
achieved good outcomes on that schedule. Step 3 was
increased to 9 hours per week only to satisfy new State
requirements that intensive outpatient program (IOP)
services include at least 9 hours of counseling per week;
there is no evidence that the change further improved
patient outcomes. It is likely that good outcomes are
possible with even less intensive schedules. With a
schedule of 2 hours for Step 2 and 4 hours for Step 3,
for example, the intensity of each step would remain
at least twice that of the preceding step, which may be
different enough to influence behavior. 
Programs might also use senior clinical person-
nel to distribute the burden of additional counseling
more widely; this has worked well in our program. The
medical director and three remaining senior staff mem-
bers each provide several hours of group counseling
each week, for a total of about 25 hours of addi-
tional services weekly. The primary counseling staff
delivers all of the individual sessions for a caseload
of about 40 patients. A comprehensive and user-friendly
manual is being developed to assist others who want
to implement the MSC approach in their settings. 
Funding
MSC services are fully supported by annual block grant
funding that uses a State-approved sliding fee sched-
ule based on income and number of dependents.  The
program receives the same level of grant funding per
treatment slot as other publicly supported programs
in Baltimore. Although many patients are uninsured,
we have reimbursement agreements with several third-
party insurers and with many managed care organi-
zations. Under these agreements, the program can bill
for IOP services for Step 3 patients. This new revenue
stream supports additional billing staff and provides
an opportunity to upgrade equipment and generally
improve the program’s infrastructure. 
Staff and Patient Acceptance
The MSC approach has been widely accepted by the
staff and patients. The active involvement of senior
staff members in the day-to-day care of patients who
have responded poorly to low-intensity care has proven
an effective method for supporting the difficult work
of primary counselors, who no longer have the pri-
mary responsibility of managing these patients.
Staff morale has been improved by the counselors’ hav-
ing access to a wider range of interventions—that is,
the variety of counseling groups and intensities offered
by the steps—than existed prior to our adoption of
the MSC approach.
Patients express a mix of positive and negative
reactions to MSC—often simultaneously. Very few
believe at the outset of a treatment episode that they
will require the more intense steps of care, and most
react with some anxiety and anger when the change
occurs. It is important to continually educate patients
about the principles underlying MSC and remind
them that negative feelings about more intensive inter-
ventions are a normal and reasonable response.
Nevertheless, most patients tolerate the approach well,
and many strongly endorse it, as evidenced by the fol-
lowing observations:
• Short- and long-term retention rates in the program
equal or exceed those of other  programs using
methadone in Baltimore; and
• We had to increase the number of group services
because patients in Step 1 who were previously
exposed to more intense steps of care began to request
more counseling. 
Over the past few years, several drug abuse treat-
ment experts visited the program to observe the MSC
approach and talk with patients. The visitors typically46 • SCIENCE & PRACTICE PERSPECTIVES—JULY 2002 
asked patients what they liked most and least about
the program. Patients most often reported the great-
est appreciation and the greatest dislike for the same
program feature—the escalating intensities of weekly
counseling. Their response illustrates a crucial ele-
ment in the therapeutic process: the staff’s ability to
help patients understand and accept that the inter-
ventions they like least are often the ones most likely
to help them.
The MSC program has yielded strong initial sig-
nals of efficacy. The next step will be to identify the
elements that can support its successful adoption into
the wider community. Adapting programs that have
worked in a single setting to produce good results in
a wide variety of settings is one of the most complex
challenges to improving the effectiveness of drug abuse
treatment in this country, and one that calls for con-
siderable collaboration between research and treat-
ment professionals. 
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The changing methadone population
Chris Farentinos:The methadone population has
changed. Today we are treating a jobless, skill-less pop-
ulation that is much more difficult to treat than the
patients of decades past. Still, I am not sure I really see
any difference in the effectiveness of methadone today
compared to 10 years ago. I think you have one-third
of people who will benefit, stay on methadone, get
good results, improve their life conditions, get a job.
You have a middle third who will have some relapses
and will struggle, and might diminish the rate of crim-
inal offenses related to drug-seeking. Then you have
the bottom third who cycle through programs.
Doug Ziedonis:The field of addiction has more com-
plicated patients now than in the past, because some
of the easier patients got treatment and moved for-
ward. In the 1980s, when the 28-day programs started,
their success rate was phenomenal, probably because
lots of people got into treatment who should have been
treated as outpatients. The methadone programs that
are left get all the really tough cases: dually diagnosed,
polydrug, polylife problems. Methadone programs
always get all the toughest cases.
Juice alone will work for some people, but not
for tougher cases. So what are you going to do for that
group? How do we strengthen the social treatment in
these different places? Part of it is bringing over mod-
els from other settings, as Brooner and Kidorf 
have done.
What community programs can gain from
the MSC model
Ziedonis: Having behavioral contracts in methadone
treatment isn’t a new thing, even in outpatient set-
tings. The big issue is always, what are the consequences
going to be? Are we going to discharge patients if they
take drugs? Are we going to push them to a high level
of care? Do we have a high level care that they can
go to? Are we going to make them go to more NA
meetings in the community?
Brooner and Kidorf’s paper is good because here
is one program spelling out the way it thinks about
these issues. Some of the smaller programs that
don’t have big psychosocial treatment components
still have behavioral plans, but theirs don’t offer as
many benefits, such as an IOP [intensive outpatient
program] for patients who are doing well as inpatients.
They are more limited on what positive perks there
can be and usually only have negative consequences.
And, from my experience, they usually are not rig-
orous in kicking out people who use drugs.
RESPONSE: IMPLEMENTING MOTIVATIONAL STEPPED CARE
The methadone
population has
changed. Today
we are treating
a jobless, skill-
less population
more difficult
to treat than
the patients of
decades past.
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